A placebo-controlled, double-blind, randomised trial of magnesium-pyridoxal-5'-phosphate-glutamate for hypercholesterolaemia and other clinical–chemical risk factors of cardiovascular disease in a primary care setting

Author: Schuitemaker G.E.   van der Pol G.A.   Aretz C.P.M.   Dinant G.J.  

Publisher: Springer Publishing Company

ISSN: 0031-6970

Source: European Journal of Clinical Pharmacology, Vol.56, Iss.12, 2001-03, pp. : 857-863

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content